Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Pizzuti

Showing results (21-30 of 120) with videos related to

Pageof 12
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|April 19, 2015
Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective studyLuigi Di Lauro, Laura Pizzuti, Maddalena Barba, et al.
Cells|August 7, 2021
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant SettingAntonino Grassadonia, Vincenzo Graziano, Laura Iezzi, et al.
Breast (Edinburgh, Scotland)|January 9, 2017
Long-term outcome of breast cancer patients with pathologic N3a lymph node stageAntonino Grassadonia, Patrizia Vici, Teresa Gamucci, et al.
The Breast Journal|April 2, 2019
Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidityRossella Martinello, Paolo Becco, Patrizia Vici, et al.
Breast (Edinburgh, Scotland)|May 21, 2017
Reply to Kadri Altundag: Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage?Antonino Grassadonia, Patrizia Vici, Teresa Gamucci, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 10, 2013
Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancerLuigi Di Lauro, Patrizia Vici, Franca Belli, et al.
Future Oncology (London, England)|April 22, 2017
ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational studyLuca Moscetti, Lucia Mentuccia, Patrizia Vici, et al.
Cancer Biology & Therapy|March 3, 2016
Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohortMassimiliano D'Aiuto, Andrea Chirico, Michele Antonio De Riggi, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 13, 2011
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM studyPatrizia Vici, Giuseppe Colucci, Francesco Giotta, et al.
Expert Review of Anticancer Therapy|December 10, 2013
Hot flushes in women with breast cancer: state of the art and future perspectivesMaddalena Barba, Laura Pizzuti, Domenico Sergi, et al.
Pageof 12

Showing results (21-30 of 120) with videos related to

Sort By:
Pageof 12
Journal of Experimental & Clinical Cancer Research : CR|April 19, 2015
Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective studyLuigi Di Lauro, Laura Pizzuti, Maddalena Barba, et al.
Cells|August 7, 2021
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant SettingAntonino Grassadonia, Vincenzo Graziano, Laura Iezzi, et al.
Breast (Edinburgh, Scotland)|January 9, 2017
Long-term outcome of breast cancer patients with pathologic N3a lymph node stageAntonino Grassadonia, Patrizia Vici, Teresa Gamucci, et al.
The Breast Journal|April 2, 2019
Trastuzumab-related cardiotoxicity in patients with nonlimiting cardiac comorbidityRossella Martinello, Paolo Becco, Patrizia Vici, et al.
Breast (Edinburgh, Scotland)|May 21, 2017
Reply to Kadri Altundag: Do cut-off values of lymph node ratio and presence of perineural invasion affect survival in breast cancer patients with pathologic N3a lymph node stage?Antonino Grassadonia, Patrizia Vici, Teresa Gamucci, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|December 10, 2013
Docetaxel, oxaliplatin, and capecitabine combination chemotherapy for metastatic gastric cancerLuigi Di Lauro, Patrizia Vici, Franca Belli, et al.
Future Oncology (London, England)|April 22, 2017
ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational studyLuca Moscetti, Lucia Mentuccia, Patrizia Vici, et al.
Cancer Biology & Therapy|March 3, 2016
Body mass index and treatment outcomes following neoadjuvant therapy in women aged 45 y or younger: Evidence from a historic cohortMassimiliano D'Aiuto, Andrea Chirico, Michele Antonio De Riggi, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 13, 2011
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM studyPatrizia Vici, Giuseppe Colucci, Francesco Giotta, et al.
Expert Review of Anticancer Therapy|December 10, 2013
Hot flushes in women with breast cancer: state of the art and future perspectivesMaddalena Barba, Laura Pizzuti, Domenico Sergi, et al.
Pageof 12